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Background: Chronic obstructive pulmonary disease (COPD) reduces exercise capacity, but lung function
parameters do not fully explain functional class and lung-heart interaction could be the explanation. We evaluated
echocardiographic predictors of mortality and six minutes walking distance (6MWD), a marker for quality of life and
mortality in COPD.
Methods: Ninety COPD patients (GOLD criteria) were evaluated by body plethysmography, 6MWD and advanced
echocardiography parameters (pulsed wave tissue Doppler and speckle tracking).
Results: Mean 6MWD was 403 (± 113) meters. All 90 subjects had preserved left ventricular (LV) ejection fraction
64.3% ± 8.6%. Stroke volume decreased while heart rate increased with COPD severity and hyperinflation. In 66% of
patients, some degree of diastolic dysfunction was present. Mitral tissue Doppler data in COPD could be interpreted
as a sign of low LV preload and not necessarily an intrinsic impairment in LV relaxation/compliance. Tricuspid
regurgitation (TR) increased with COPD severity and hyperinflation. Age (p < 0.001), BMI (p < 0.001), DLCO SB
(p < 0.001) and TR (p 0.005) were independent predictors of 6MWD and a multivariable model incorporating heart
function parameters (adjusted r2 = .511) compared well to a model with lung function parameters alone (adjusted
r2 = .475). LV global longitudinal strain (p = 0.034) was the only independent predictor of mortality among all
baseline, body plethysmographic and echocardiographic variables.
Conclusions: Among subjects with moderate to severe COPD and normal LVEF, GLS independently predicted all-
cause mortality. Exercise tolerance correlated with standard lung function parameters only in univariate models; in
subsequent models including echocardiographic parameters, longer 6MWD correlated independently with milder
TR, better DLCO SB, younger age and lower BMI. We extended the evidence on COPD affecting cardiac chamber
volumes, LV preload, heart rate, as well as systolic and diastolic function. Our results highlight lung-heart interaction
and the necessity of cardiac evaluation in COPD.
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Chronic obstructive pulmonary disease (COPD) is asso-
ciated with increased pulmonary vascular resistance by
hypoxic pulmonary arterial vasoconstriction, and by
mechanical compression of the pulmonary vasculary bed
due to air-way obstruction and air trapping [1-4]. Em-
physema is associated with pulmonary alveolar and vas-
cular destruction which leads to increased ventilation-
perfusion mismatching with reduced diffusing capacity
and to loss of pulmonary elastic recoil and parenchymal
support for collapsible airways. This results in hype-
rinflation with elevated intrathoracic pressure, which is
associated with reduced left ventricular end-diastolic
volume, stroke volume and cardiac output, estimated by
magnetic resonance [5]. Recently, Barr et al. showed that
the extent of computer tomography measured emphy-
sema and airflow obstruction are linearly related to im-
paired left ventricular filling, reduced stroke volume, and
lower cardiac output without changes in left ventricular
ejection fraction (LVEF) already in mild to moderate
COPD, [6] and Watz et al. found a clear association be-
tween hyperinflation (inspiratory capacity to total lung
capacity ratio - IC/TLC) and decreasing dimensions of
all four cardiac chambers estimated by echocardiography
for the entire spectrum of COPD severity [7]. Another
readily available echocardiography estimate is peak tris-
cupidal regurgitation, a proxy for pulmonary artery
pressure (PAP). In COPD, hyperinflation, wedge, right
atrial, and invasively measured PAP increase parallel
during tachypnea and exercise [8]. PAP is independ-
ently associated with reduced exercise function in pa-
tients with severe COPD, who were evaluated for lung
transplantation [9].
The aim of the present study was to determine if 1)
the simple echocardiographic estimates of peak tricus-
pidal regurgitation and measures of impaired ventricular
filling predict six minutes walking distance (6MWD) in
patients with moderate COPD and 2) how more ad-
vanced echocardiographic pulsed wave tissue Doppler
and speckle tracking variables relate to body plethys-
mography, 6MWD prediction and mortality in COPD.
Methods
We included 101 COPD patients without history of car-
diovascular disease and normal LVEF (>50%) from the
outpatient clinic of the department of pulmonary dis-
eases, Hillerød Hospital, Denmark. COPD diagnosis was
according to GOLD diagnostic criteria [10] and a post-
bronchodilator spirometry with FEV1/FVC < 0.70. GOLD
class I (mild COPD) was defined by a forced expiratory
volume during one second (FEV1) ≥80% of normal,
GOLD class II (moderate COPD) by FEV1 50–79% of
normal, GOLD class III (severe COPD) by FEV1 of
30–49% of normal and GOLD class IV (very severeCOPD) by FEV1 <30% of normal. Severity of airflow
limitation was based on post-bronchodilator FEV1. We
hypothesized that abnormalities in echocardiographic
variables would be most overt in the most pulmonary ill
patients, why the primary inclusion goal was to recruit
participants in GOLD class II - IV. Patients were ap-
proached during outpatient clinic consultation, based
on their most recent spirometry result. These values
tend to fluctuate and especially borderline cases can re-
categorize between measurements, why also a few
GOLD class I patients were included. Patients in GOLD
class IV were relatively more reluctant to participation
or too ill with domestic oxygen therapy. After written
consent, patients were tested on the same day by body
plethysmography, transthoracic echocardiography and 6
MWD, in this order. Echocardiographic and pulmonary
function measures were made at rest. One patient was
excluded because of previous pulmonary lobectomy, 3
patients because of either missing body plethysmography
or transthoracic echocardiography, 5 patients due to
previous myocardial infarction and 2 patients due to
congestive heart failure. This study was approved by the
local ethics committee (H-A-2008-138).
Transthoracic echocardiography
Transthoracic echocardiography was performed blinded
to all other data, using a Vivid 7 ultrasound system (GE
Healthcare). Images were obtained from the parasternal
views (long axis and short axis), the apical four-chamber
view and the subcostal view. All analyses were per-
formed using dedicated software (EchoPAC, GE). Echo-
cardiographic assessment was performed according to
guidelines [11-13].
Systolic function
LVEF was evaluated by Simpson’s biplane method, also
yielding the body surface area (BSA) indexed LV volumes:
stroke volume index (SVI) = left ventricular end-diastolic
volume index (LVEDVI) – left ventricular end-systolic vol-
ume index (LVESVI). Tissue Doppler–derived mitral la-
teral annular systolic velocity (S’ LV) and longitudinal
global strain (GLS LV) were evaluated using an automatic
tracing algorithm with manual adjustment.
Two-dimensional speckle tracking was performed
using a semiautomatic algorithm (Automated Function
Imaging, GE Healthcare). Manual positioning of 3 points
(2 annular and 1 apical) was performed in the 4-
chamber apical projection, enabling the software to
semi-automatically track the myocardium. The region
of interest was adjusted to cover the thickness of the
myocardium. Aortic valve closure was identified on
continuous-wave Doppler recording through the aortic
valve. Careful inspection of tracking and manual correc-
tion, if needed, was performed. The Automated Function
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5 of 6 segments were sufficiently tracked. The algorithm
then calculated overall GLS as the mean value [14]. Right
ventricle (RV) systolic function was evaluated using tri-
cuspid annular plane systolic excursion (TAPSE), tissue
Doppler–derived tricuspid lateral annular systolic velocity
(S’ RV), and longitudinal GLS RV tracing the RV free wall
in the apical 4-chamber with manual adjustments. We
also measured the peak systolic pressure gradient of the
tricuspid regurgitation (TR) jet (mmHg).
Diastolic function
Measurement of LV and RV diastolic function was as-
sessed by pulsed Doppler of the mitral/ tricuspid inflow
(early wave (E), atrial wave (A), E/A ratio, deceleration
time (DT) and slope of the early transmitral/trans-
triscuspidal flow), tissue Doppler-derived diastolic early
(e’) and late (a’) velocities of the lateral mitral/tricuspid
annulus as well as tissue Doppler-derived isovolumetric
contraction time (IVCT), isovolumetric relaxation time
(IVRT), ejection time (ET) and the E/e’ ratio. Diastole is
divided into relaxation, represented in part by IVRT, and
diastolic filling, represented in part by deceleration time
of the early transmitral/transtriscuspidal flow and ra-
tio of the peak velocity of the early E-wave to atrial
A-wave (E/A).
Chamber volumes
Indexed left (LAVI) and right atrium (RAVI) volumes
were assessed at the end of ventricular systole (largest
volume) in the apical 4-chamber view. Indexed LV vol-
umes (ml/m2) were determined during Simpson’s bi-
plane method [13]. RV focused apical 4-chamber views
(transducer adjusted to focus on the RV chamber, with
the goal of maximizing chamber size) were used to ob-
tain BSA indexed basal (RVD1I), mid cavity (RVD2I)
and longitudinal dimension (RVD3I) at end-diastole.
Lung function variables
Lung function variables were measured by spirometry
and body plethysmography. Among the indexes used,
diffusion capacity of carbon monoxide transferred from
the alveoli to the capillary during a single breath
(DLCO SB) was employed as a gas exchange functional
index. Reduced DLCO SB is an index of loss of inte-
ralveolar septa as well as of restrictive pneumopathy.
FEV1 was interpreted as a measure of respiratory ca-
pacity and classifies COPD severity. The ratio of FEV1 to
the forced volume vital capacity (FEV1/FVC) is a meas-
ure of obstruction to exhalation. Total lung capacity
(TLC) is the sum of functional residual capacity (FRC)
and inspiratory capacity (IC). The ratio of IC/TLC and
the determination of residual volume allows to judge upon
the degree of lung hyperinflation. Values of RV <140% ofpredicted are indicative of mild, values between 140
and 170% of moderate, and values >170% of severe
hyperinflation [15].
Oxygen delivery index
The oxygen delivery index (DpO2) was calculated by
the following equation, relying on pulse oximetry
(SpO2): DpO2 = 1.34 × Hb conc. × Cardiac Index ×
(SpO2/100) ml/min/m2.
Statistics
Continuous variables are presented as median and inter-
quartile range (IQR) or mean and standard deviation
(±SD). We used the Kruskal-Wallis test to explore sig-
nificant differences in median values. Non parametric
correlation was tested by Pearson correlation. Kaplan
Meier curves and log rank test was used to estimate
mortality differences according to GOLD class. All uni-
variable predictors with P <0.1 were entered in multi-
variable linear and binary logistic regression analysis of
exercise tolerance and all-cause mortality predictors. A
P-value <0.05 was considered significant. Statistical tes-
ting was performed using the PASW Statistics software
package, version 19 (SPSS, Inc., Chicago, IL, USA).
Results
We included 90 COPD patients without previous ische-
mic heart disease, congestive heart failure, LVEF <50%,
aortic stenosis or mitral insufficiency. The mean 6MWD
was 403 ± 113 meters. Baseline characteristics in terms
of age and gender were balanced and body plethysmog-
raphy parameters were associated with GOLD classes
as expected. Risk factors of underlying cardiac disease
were unevenly dispersed. Frequencies of diabetes and
dyslipidemia were very low, however 30–40% hyperten-
sive patients were present in GOLD class II and III
(Table 1).
Systolic function
All subjects had preserved LV ejection fraction 63.9%
(± 8.8) and overall GLS was 18.4 (± 3.8). Stroke volume
decreased and heart rate increased significantly with in-
creasing COPD severity (Table 2). Right ventricular
function in terms of TAPSE, S’RV and GLS RV were not
associated with COPD severity. However, the basal right
ventricular diameter tended to increase with COPD
(Table 2). TR increased significantly with COPD severity
in terms of FEV1 (r = −.416; P <0.001) and with hype-
rinflation and emphysema in terms of residual volume
(r = .297; P = 0.004), function residual capacity (r = .322;
P = 0.002) and IC/TLC (r = −.410; P <0.001)) and DLCO
SB (r = −.367; P <0.001) as well as airway obstruction
(FEV1/FVC) (r = −.373; P <0.001). Furthermore, we
Table 1 Baseline variables
GOLD class
I II III IV P
N 5 35 41 9
Age 73 (62–77) 70 (63–77) 66 (63–74) 67 (65–71) 0.740
Female (%) 3 (60.0) 22 (62.9) 27 (65.9) 2 (22.2) 0.205
Hypertension 1 (20) 13 (40.6) 15 (37.5) 1 (11.1) 0.309
Diabetes 1 (20) 3 (9.1) 1 (2.3) 0 (0) 0.038
Dyslipidemia 1 (20) 10 (30.3) 5 (12.5) 0 (0) 0.015
BMI 29 (23–29) 26 (23–30) 24 (21–26) 24 (17–29) 0.109
FEV1,% of predicted 84.8 (83–86.8) 57.6 (52.9–69.9) 40.1 (36.4–43.4) 25.8 (24.6–27.5) <0.001
FVC,% of predicted 101 (92.5–109.6) 96.4 (82.8–107.8) 82.6 (71.1–89.1) 52.2 (49–63) <0.001
FEV1/FVC,% 69 (65–74) 51 (44–60) 41 (35–45) 38 (35–41) <0.001
IC,% of predicted 98.9 (95.8–121.8) 97.3 (87.7–109.8) 80.4 (65.3–96.4) 65.7 (56.1–67.2) <0.001
TLC,% of predicted 105.9 (98.3–115.4)) 122.7 (105.3–134.8) 126 (111.8–134.4) 128.6 (115.1–135)) 0.127
Residual volume,% of predicted 102.9 (101.6–139.2) 155.5 (139.4–185.6) 190 (172–215.4) 241.8 (195.2–252.6) <0.001
FRCpleth,% of predicted 106.7 (100.5–113.2) 146 (117–170.7) 167.2 (148–179.5) 185.9 (168.7–198.9) <0.001
TLCO SB,% of predicted 75.1 (66.7–82.7) 52.6 (43.7–67.3) 40.7 (31–49.5) 30.2 (20.8–42.5) <0.001
IC/TLC 0.40 (0.39–0.46) 0.34 (0.30–0.38) 0.27 (0.22–0.33) 0.22 (0.20–0.23) <0.001
Hemoglobin g/L 130 (116–147) 137 (129–150) 140 (135–147) 142 (130–154) 0.641
Hemoglobin mmol/L 8.1 (7.2–9.1) 8.5 (8–9.3) 8.7 (8.4–9.1) 8.8 (8.1–9.5) 0.641
DpO2 ml/min/m
2 281 (279–294) 326 (290–413) 295 (251–329) 366 (349–391) 0.007
SATrest 95 (95–96) 96 (94–96) 95 (96–96) 93 (91–95) 0.048
SATmin 93 (89–95) 91 (87–93) 88 (86–91) 84 (80–85) 0.001
Δ SAT 2 (1–6) 4 (3–6) 7 (4–9) 9 (7–10) 0.003
6MWD 520 (450–575) 425 (355–510) 380 (310–450) 355 (325–375) 0.009
TR (mmHg) 27.8 (26.0–28.8) 29.1 (25.8–35.0) 33.2 (28.3–41.0) 40.5 (37.4–48.3) 0.001
FVC = forced volume vital capacity; FEV1 = forced expiratory volume in one second; TLC = total lung capacity; FRCpleth = functional residual capacity; IC = inspiratory
capacity; DLCO SB = Single breath diffusing capacity of the lung for carbon monoxide; IC/TLC = inspiratory capacity to total lung capacity ratio; SATrest = Saturation
at rest; SATmin =Minimal saturation during 6MWD; Δ SAT = SATrest - SATmin; 6MWD = 6 minutes walking distance.
Table 2 Systolic variables and ventricular volumes
GOLD class
I II III IV P
Left systolic function
LVEF 64 (59–67) 62 (58–68) 69 (65–76) 57 (57–57) 0.138
Heart rate 69 (65–76) 80 (74–85) 80 (75–86) 87 (85–88) 0.030
SVi (ml/m2) 22.0 (21.8–28.1) 22.9 (21.0–26.5) 19.4 (17.8–22.3) 20.7 (18.3–24.9) 0.001
CI (L/min−1*m2) 1.7 (1.6–1.8) 1.8 (1.6–2.0) 1.6 (1.3–1.8) 1.8 (1.7–2.1) 0.015
S’ (LV) (cm/s) 9 (7–9) 8 (7–9) 9 (7–11) 9 (7–10) 0.383
GLS (LV) 15.7 (15.3–17.5) 16.8 (14.8–20.2) 19.4 (16.4–22.4) 18.2 (14.4–19.2) 0.066
Right systolic function
TAPSE 2.2 (2.2–2.3) 2.3 (2.1–2.5) 2.3 (2.1–2.6) 2.2 (2.1–2.4) 0.885
S’ (RV) (cm/s) 13 (10–14) 13 (12–14) 14 (13–15) 13 (12–14) 0.428
RVDi 18.3 (18.0–21.64) 20.0 (17.4–21.3) 20.4 (17.4–22.4) 22.3 (19.2–23.3) 0.164
GLS (RV) 26.2 (18.7–33.7) 23 (19.2–26.6) 23.8 (19.7–27) 22.8 (18–34.4) 0.968
CI = Cardiac index; SVi = stroke volume index; TR = Tricuspidal regurgitation; GLS = Global strain; LVEF = Left ventricular ejection fraction.
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Table 3 Diastolic variables
GOLD class
I II III IV P
Left heart diastolic function
LAi 21 (20–22) 18 (15–22) 18 (14–23) 14 (14–19) 0.402
Lateral Ee’ (LV) 9.42 (8.1–11.9) 8.66 (7.7–10) 8.92 (7.8–11) 6.9 (6.4–9.2) 0.451
Mitral E/A 0.91 (0.73–1.31) 0.80 (0.62–0.99) 0.85 (0.69–1.14) 0.85 (0.68–0.97) 0.360
DT (ms) 236 (215–292) 239 (205–254) 226 (173–250) 212 (176–246) 0.762
IVRT (ms) 90 (87–135) 87 (71–99) 79 (65–11) 77 (76–86) 0.891
Right heart diastolic function
RAi 20 (14–21) 19 (15–22) 19 (15–27) 21 (19–24) 0.836
Lateral Ee’ (RV) 4 (3–4) 4 (4–5) 4 (3–5) 4 (4–4) 0.563
Tricuspidal E/A 1.2 (1.0–1.3) 1.1 (0.9–1.3) 1.1 (1.0–1.3) 1.2 (1.1–1.2) 0.813
DT (ms) 225 (205–232) 208 (171–243) 215 (169–272) 155 (153–229) 0.493
IVRT (ms) 76 (63–86) 86 (74–100) 92 (79–101) 93 (77–98) 0.497
Table 4 Diastolic variables in the overall population in
comparison to reference values from normal populations
from guidelines publications
Measured values Reference values
Left heart diastolic function
E 80 (±18) 73 (± 19)[11]
A 90 (±23) 69 (± 17)[11]
E/A ratio 0.99 (± 0.55) 0.96 (± 0.18)[11]
Lateral e’ (cm/s) 9.2 (± 2.8) 12.9 (± 3.5)[11]
Lateral E/e’ ratio 9.1 (± 2.6) 6.7 (± 2.2)[11]
Lateral e’/a’ ratio 0.92 (± 0.42) 0.9 (± 0.4)[11]
IVRT (ms) 93 (± 23) 87 (± 7)[11]
DT (ms) 226 (± 50) 200 (±29)[11]
Right heart diastolic function
E 55 (± 11) 54 (52–56)[12]
A 49 (± 11) 40 (38–41)[12]
E/A ratio 1.2 (± 0.25) 1.4 (1.4–1.5)[12]
Lateral e’ (cm/s) 11.9 (± 2.7) 14 (CI 13–14)[12]
Lateral E/e’ ratio 4.27 (± 2) 4 (CI 4–4)[12]
Lateral a’ (cm/s) 119.1(± 4.6) 13 (CI 12–14)[12]
Lateral e’/a’ ratio 0.66 (± 0.24) 1.2 (CI 1.1–1.3)[12]
IVRT (ms) 89 (± 19) 48 (CI 43–53)[12]
DT (ms) 210 (± 56) 174 (CI 163–186)[12]
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and DpO2 (r = −.322, P = 0.016).
As hypertension was unevenly dispersed between
GOLD class groups, we investigated the possible differ-
ences between patients with known hypertension and
non-hypertensive patients in order to account for a
possible afterload effect on ventricular function and
volumes. We found no significant differences regarding
GLS, LVEF by Simpson biplane as well as ventricular
and atrial camber volumes.
Diastolic function
Diastolic measures are shown by GOLD class (Table 3)
and the comparison to reference values from guidelines
publications is shown in Table 4. When applying the rec-
ommendations for evaluation of left ventricular diastolic
function, assessed by e’, atrial volume, and mitral inflow
patterns identified by E/A ratio and DT, [11] this COPD
population with normal LVEF had a high incidence of
diastolic dysfunction: 25 (34.2%) had normal function,
34 (40.8%) had diastolic dysfunction grade I (impaired
relaxation pattern), 18 (20%) had diastolic dysfunction
grade II (pseudonormalized flow), and 1 (1.3%) had dia-
stolic dysfunction grade III (restrictive pattern).
Exercise tolerance
Diastolic dysfunction was not significantly associated
with exercise capacity; Normal: (median 425 IQR 355–
480 m); grade I: (390 IQR 310–450 m); grade II: (420
IQR 290–550 m); grade III: (100 m) (P = 0.278)].
In multivariable linear regression analysis age, BMI,
DLCO SB and TR were independent predictors of
6MWD distance. A multivariable model incorporating
TR as the only independent heart function parameter pre-
dicting 6MWD increased the adjusted r2 value comparedto a model with lung function parameters alone from
0.475 to 0.511 (Table 5).
All-cause mortality predictors
Median follow up time was 1387 (IQR 1122–1472) days.
Increasing GOLD class was not consistently associated
with increasing mortality: [GOLD class I: 1 (20%)
Table 5 Univariable and multivariable predictors of distance (m) performance in 6 minutes walking test
Univariable predictors Multivariable predictors Multivariable predictors
Model 1 Model 2
β P β P β P
Age −.305 0.004 −.406 <0.001 −.323 <0.001
Gender .153 0.064





DLCO SB .390 <0.001 .547 <0.001 .608 <0.001
SATrest .288 0.006
TR −.386 <0.001 −.239 0.005
E/e’ −.285 0.015
BMI, gender, residual volume, functional residual capacity, total lung capacity and cardiac stroke volume index were also tested for univariable prediction but
were insignificant.
Model 1 tests multivariable prediction of baseline variables (age, gender, BMI) and lung function variables only (FEV1, FEV1/FVC, IC, IC/TLC, TLC, RV, DLCO
SB, SATrest).
Model 2 tests echochardiographic univariable predictors of 6MWD (TR, CI, E/e’) added to model 1. Overall adjusted r2 values for model 1 and 2 are 0.475 and
0.511 respectively.
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III: 9 events (22%) and GOLD class IV: 4 events (50%),
log-rank test P = 0.694]. GLS (LV) was the only indepen-
dent predictor of all cause long term mortality among all
baseline, body plethysmographic and echocardiographic
variables (Table 6).Discussion
The main results were the following; i) In patients with
moderate to severe COPD and normal LVEF, GLS (LV)
was the only independent predictor of all-cause long
term mortality. ii) TR was an independent predictor of
exercise tolerance in patients with moderate to severe
COPD. iii) COPD severity is associated with significant
changes in cardiac chamber volumes, heart rate and left
ventricular filling properties.Table 6 All univariable predictors with P <0.1 are shown
and were entered in a multivariable analysis of all-cause
long term mortality
Univariable predictors Multivariable predictors
HR (CI) P OR P
Male 2.90 (1.30–6.47) 0.009 2.94 (0.86–10.0) 0.085
FEV1/FVC 0.96 (0.93–0.99) 0.038
DLCO SB 0.97 (0.94–0.99) 0.028
GLS (LV) 0.78 (0.65–0.93) 0.006 0.82 (0.68–0.98) 0.034
6MWD 0.99 (0.99–1.00) 0.046
All other variables in Table 1, 2, 3 were tested but non-significant.Mortality
All-cause mortality in GOLD class II & III was very
similar, suggesting that the GOLD classification does not
separate mortality risk properly. In univariable survival
analysis, 6MWD, FEV1/FVC, DLCO SB and GLS (LV)
correlated with mortality; in multivariable survival ana-
lyses however, mortality was predicted by GLS (LV) only
and not by functional capacity, COPD severity or right
ventricular structure and function (Table 6). We also
found a paradoxical trend of higher GOLD class being
associated with better LV systolic function as assessed by
higher GLS (LV) values (Table 2). In a recent meta-
analysis, normal ranges for GLS were established at a
mean of 19.7 % (95% CI, 18.9 - 20.4 %) [16]. In compari-
son, values across all GOLD classes were lower in this
population and in line with a recent study of sub-clinical
LV dysfunction [17]. As GLS (LV) was inversely associ-
ated with mortality, this suggests that GLS (LV) may not
mediate the association between COPD severity and
mortality. If so, one may speculate that the data re-
present separate and independent pathophysiological
contexts (left heart disease, functional capacity, lung dys-
function, mortality), meaning that the additive informa-
tion by echocardiography is likely to be prognostic
relevant information unrelated to COPD. This may also
contribute to explain why right ventricular structure and
functions were not significantly related to 6MWD and
mortality. In contrast, the positive relationship of DLCO
SB with better functional capacity and higher TR with
shorter 6MWD confirm the association of COPD sever-
ity and functional capacity.
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A recently emerged hyperinflation parameter is the in-
spiratory fraction (IC/TLC), which is associated with
emphysema on high resolution CT [18] and independ-
ently predicts exercise capacity, [19] acute disease exac-
erbations, [20] and mortality in COPD patients [21]. We
extended the evidence regarding the pattern of decreas-
ing stroke volume and increasing heart rate with COPD
severity and hyperinflation (Table 2 & 7) – the ‘shrinking
heart’ in COPD. We also found the opposite relationship
for heart rate and hyperinflation (Table 7). Previously,
Barr et al. showed in a population-based cohort with
mild to moderate COPD and without overt cardiovascular
disease, that a greater extent of emphysema on CT scan-
ning and more severe airflow obstruction (FEV1/FVC)
were related to impaired left ventricular filling [6]. In a
magnetic resonance study, patients with severe emphy-
sema had approximately 40% reductions in SVI compared
to control subjects [5]. Decreasing heart size is not only
present in severe emphysema. Watz et al. showed a clear
association between hyperinflation (IC/TLC) and decreas-
ing volumes for all four cardiac chambers for the entire
spectrum of COPD severity [7].
There were no clear association of S’ or GLS (LV) with
GOLD classes (Table 2). Unexpectedly, as cited above,
we found a seemingly increasing dynamic heart with a
tendency towards increasing S’ (LV) and GLS (LV) with
increasing severity of COPD (Table 2). We see two pos-
sible explanations: Firstly, left ventricular filling pressure
has an impact on left ventricular longitudinal systolic
strain rate in preserved LVEF: lower filling pressures
(usually considered normal filling pressures) are associ-
ated with higher peak systolic strain rate [22]. Secondly,
these findings may also be explained by a hypoxia or
baroreflex mediated increase in cardiac sympathetic
nerve activity which will increase cardiac inotropy and
chronotropy [23], which is supported by our findings of
a significant. We found a significant inverse relationship
between GLS and DpO2 (r = −.322, P = 0.016).
All of the above implies that increasing COPD severity
and hyperinflation leads to reduced LV preload, entailing
reduced stroke volume, but maintained cardiac output
due to an increased heart rate. Alongside there are indi-
ces of a compensating increased longitudinal function
with increasing COPD severity, possibly due to hypoxiaTable 7 Correlations of ventricular chamber volumes and
measures of COPD severity and hyperinflation
HR LVEDVI SVI CI RVD1I
FEV1 (%) β −.268 .265 .391 .202 −.218
P 0.011 0.015 <0.001 0.065 0.061
IC/TLC β −.190 .339 .432 .339 −.335
P 0.075 0.002 <0.001 0.002 0.003induced and/or lower preload and filling pressures mediat-
ing increased ino- and chronotropy, in an otherwise longi-
tudinal depressed left ventricle that predicts mortality.
Right heart systolic function and pressure
Another finding of the present study was that greater
peak TR independently predicted decreasing exercise
function in moderate COPD, (Table 5) which is in line
with previous reports, [9] although results are conflicting
[24]. Recently, Boerritger et al. showed that only in
COPD patients with severe pulmonary hypertension (in-
vasively measured mPAP >40 mmHg found in rare 4%
of patients), exercise capacity is limited because of an
exhausted circulatory reserve [25]. This possibly indi-
cates that TR in this population with moderate to severe
COPD is a marker, rather than a cause of decreased ex-
ercise capacity. The feeble but consistent increase of TR
with measures of COPD severity and hyperinflation did not
result in depressed right long-axis ventricular function, as
S’ RV and TAPSE did not differ from normal individuals
[12] and TAPSE, S’RVand GLS RV were not associated with
lung function parameters (Table 2). Yet, this was at the ex-
pense of a slightly dilated right ventricle associated with
hyperinflation (Table 7), possibly due to increased right
ventricular filling pressures, as mean IVRT RV was clearly
increased compared to normal subjects (Table 4). Our find-
ing of RV dilatation with a lowered LV size with COPD se-
verity and hyperinflation fits in a mechanism of increased
RV afterload by increased pulmonary artery pressure (and
hence increased TR), leading to LV preload reductions. Sev-
eral studies have shown right ventricular hypertrophy in
COPD, [24,26,27] supporting the concept of increased RV
afterload. Yet here, our results are opposed to Watz et al.
who found a decreasing RV size with hyperinflation [7].
The presented values of SVI and CI (Table 2) are in com-
parison to recent studies rather low for moderate to severe
COPD [9].
Left heart diastolic function
Unlike previous reports, we did not find decreasing E/A
and increasing deceleration time of E with increasing
hyperinflation [7] or COPD severity, [28] nor did we find
decreasing E/A with increasing SPAP [29]. In our overall
population, numerically E/A and DT was very similar
compared to normal individuals [11]. However, abnormal
left ventricular diastolic filling patterns, assessed by e’,
LAVI, and mitral inflow patterns (E/A and deceleration
time of E), were present in 66% of patients, which compares
to a recently found 54% prevalence by Cuttica et al. We
also found lower E/e’ values to be univariably associated
with impaired functional capacity (Table 5), confirming pre-
vious results by Cuttica et al. [24]. Decreasing E/e’ with in-
creasing COPD severity indicates lower left ventricular
filling pressures, [11] which lends support to the concept of
Schoos et al. BMC Cardiovascular Disorders 2013, 13:84 Page 8 of 9
http://www.biomedcentral.com/1471-2261/13/84reduced preload in COPD. We also confirmed previous
findings that left IVRT LV was unaffected by hyperinflation
[7], which might indicate that LV diastolic dysfunction in
patients with COPD seems not to be related to left ven-
tricular distensibility (ie. stiff myocardium or intrinsic im-
pairment in LV relaxation/compliance) but rather to a
reduced preload.It is important to acknowledge the prob-
lem that mitral Doppler and TD data, as well as IVRT are
all load-dependent and heart rate-dependent and therefore
should be interpreted with caution, particularly in COPD
with lower preload levels.
Right heart diastolic function
We found no significant associations of tricuspid Doppler
inflow variables (E, A, E/A) with lung function parame-
ters, but the overall population had compared to normal
individuals reduced e’, clearly elevated a’ and reduced e’/a’
(Table 4). Reduced e’/a’ may indicate reduced preload to
the right ventricle or/and increased right ventricular filling
pressure, also indicated by clearly prolonged IVRT RV
(Table 4), which reinforces the concept of increased RV
afterload.
Limitations
Our study had several limitations. The design was cross
sectional, making firm conclusions about causality im-
possible. Also, we did not have a control group which
necessitated the use of reference values from literature.
This cohort mainly represents patients from GOLD class
II and III and as a result, the findings of our study can-
not necessarily be generalized. Finally, reliability of echo-
cardiography measures of SPAP are disputed due to the
difficulty in obtaining satisfactory echo images in a po-
tential hyper inflated chest and rightward rotation of the
heart, making visualization of the tricuspid valve and
vena cava more difficult. In patients with severe emphy-
sema, echocardiographic estimates of pulmonary artery
pressures correlate very weakly with right heart catheter-
izations [30]. Also the low values of SVI/CI we found
are possibly due to imaging difficulties.
Conclusion
GLS predicts mortality in patients with moderate to se-
vere COPD and normal LVEF. TR predicts exercise cap-
acity after adjustment for lung function parameters.
COPD severity and hyperinflation are associated with in-
creased heart rate and reduced stroke volume, likely due
to reduced preload to a left ventricle. Our findings
emphasize that heart function parameters should be in-
vestigated in COPD. Pulsed wave tissue Doppler indices
of systolic and diastolic heart function in COPD did not
predict exercise capacity or mortality, however diastolic
mitral Doppler data in COPD could be interpreted as asign of low LV preload and not necessarily an intrinsic
impairment in LV relaxation/compliance.
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